Morgan Stanley Maintains Equal-Weight on Elevance Health, Lowers Price Target to $352

Benzinga · 12/18/2025 17:48
Morgan Stanley analyst Erin Wright maintains Elevance Health (NYSE:ELV) with a Equal-Weight and lowers the price target from $359 to $352.